Development and validation of a prognostic model for stage I-IIA non-small cell lung cancer: A study based on the SEER database
Asian J Surg
.
2022 Oct;45(10):2072-2073.
doi: 10.1016/j.asjsur.2022.04.100.
Epub 2022 May 5.
Authors
Sheng Wei
1
,
Jingjing Shao
2
,
Jinming Wang
3
,
Gaoren Wang
4
Affiliations
1
Department of Radiotherapy, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, 226361, China.
2
Key Laboratory of Cancer Research Center Nantong, Affiliated Tumor Hospital of Nantong University, Nantong, 226361, China.
3
Department of Oncology, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, 226361, China.
4
Department of Radiotherapy, Affiliated Tumor Hospital of Nantong University, Nantong University, Nantong, 226361, China. Electronic address: wanggaoren111@163.com.
PMID:
35527128
DOI:
10.1016/j.asjsur.2022.04.100
No abstract available
Publication types
Letter
MeSH terms
Carcinoma, Non-Small-Cell Lung* / pathology
Carcinoma, Non-Small-Cell Lung* / surgery
Humans
Lung Neoplasms* / pathology
Neoplasm Staging
Prognosis
Survival Rate